Publikation: Human lung carcinomas synthesize immunoregulatory glucocorticoids
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
The need for new options in lung cancer treatment inevitably leads back to basic research. The tumor itself and the tumor environment especially the interaction with the immune system need to be better understood to develop targeted therapies. In the context of lung cancer glucocorticoids (GC) are mainly known as a combination drug to attenuate side-effects of chemotherapies. However, endogenous extra-adrenal GC have been shown to substantially regulate local immune responses within various tissues, including the lung. In this study we investigated whether primary lung tumors have maintained the capacity to synthesize GC and may thereby regulate anti-tumor immune responses. We show that several non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC) cell lines express key steroidogenic enzymes and synthesize bioactive GC under steady state conditions. We also show that tumor-derived GC can inhibit splenic T cell activation, thus demonstrating their immunoregulatory potential. Moreover, steroidogenic enzymes were detected by quantitative RT-PCR and immunohistochemistry in tissue sections of different human lung tumors, further strengthening the idea that human lung carcinomas regulate their microenvironment by releasing immunoregulatory GC, which potentially contributes to immune evasion and treatment resistance.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
MERK, Verena M., Leonie GROB, Achim FLEISCHMANN, Thomas BRUNNER, 2023. Human lung carcinomas synthesize immunoregulatory glucocorticoids. In: Genes & Immunity. Springer Nature. 2023, 24, pp. 52-56. ISSN 1466-4879. eISSN 1476-5470. Available under: doi: 10.1038/s41435-023-00194-yBibTex
@article{Merk2023-01-18Human-59898, year={2023}, doi={10.1038/s41435-023-00194-y}, title={Human lung carcinomas synthesize immunoregulatory glucocorticoids}, volume={24}, issn={1466-4879}, journal={Genes & Immunity}, pages={52--56}, author={Merk, Verena M. and Grob, Leonie and Fleischmann, Achim and Brunner, Thomas} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/59898"> <dc:contributor>Fleischmann, Achim</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-01-23T14:00:55Z</dcterms:available> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/59898/1/Merk_2-1q2tz741yimit8.PDF"/> <dc:contributor>Merk, Verena M.</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-01-23T14:00:55Z</dc:date> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/59898/1/Merk_2-1q2tz741yimit8.PDF"/> <dc:creator>Grob, Leonie</dc:creator> <dc:rights>Attribution 4.0 International</dc:rights> <dcterms:title>Human lung carcinomas synthesize immunoregulatory glucocorticoids</dcterms:title> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/> <dc:language>eng</dc:language> <dc:contributor>Grob, Leonie</dc:contributor> <dc:creator>Merk, Verena M.</dc:creator> <dcterms:issued>2023-01-18</dcterms:issued> <dcterms:abstract xml:lang="eng">The need for new options in lung cancer treatment inevitably leads back to basic research. The tumor itself and the tumor environment especially the interaction with the immune system need to be better understood to develop targeted therapies. In the context of lung cancer glucocorticoids (GC) are mainly known as a combination drug to attenuate side-effects of chemotherapies. However, endogenous extra-adrenal GC have been shown to substantially regulate local immune responses within various tissues, including the lung. In this study we investigated whether primary lung tumors have maintained the capacity to synthesize GC and may thereby regulate anti-tumor immune responses. We show that several non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC) cell lines express key steroidogenic enzymes and synthesize bioactive GC under steady state conditions. We also show that tumor-derived GC can inhibit splenic T cell activation, thus demonstrating their immunoregulatory potential. Moreover, steroidogenic enzymes were detected by quantitative RT-PCR and immunohistochemistry in tissue sections of different human lung tumors, further strengthening the idea that human lung carcinomas regulate their microenvironment by releasing immunoregulatory GC, which potentially contributes to immune evasion and treatment resistance.</dcterms:abstract> <dc:creator>Fleischmann, Achim</dc:creator> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/59898"/> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Brunner, Thomas</dc:creator> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:contributor>Brunner, Thomas</dc:contributor> </rdf:Description> </rdf:RDF>